Intuitive Surgical stock gains as Q2 procedure growth and da Vinci installs impress
Published on 09/15/2026 at 14:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Intuitive Surgical, Inc. stock (ISIN US46120E6023) closed at USD 377.94 on Nasdaq on September 14, 2026, a gain of 2.38 percent over the prior close in an otherwise weak US equity session. According to MarketWatch on September 14, 2026, this move marked the stock's fourth consecutive day of gains and came despite declines in the S&P 500 and Dow Jones indices.
Q2 2026 growth in procedures and da Vinci installs
Beyond the recent price move, the latest available operating figures show that Intuitive Surgical continues to expand the reach of its robotic surgery platform. According to ???? in a MoneyDJ report summarizing Q2 2026, Intuitive Surgical disclosed that global installed da Vinci systems rose to 11,710 units by the end of the second quarter of 2026, with 468 new systems placed in the quarter.
The same report notes that total da Vinci surgical procedure volume in Q2 2026 increased 16 percent year over year, underlining that system expansion is being accompanied by rising utilization. ???? highlights that of the 468 new systems installed in Q2 2026, 254 were deployed under operating leases, signaling Intuitive Surgical's push to use flexible financing models to support hospitals and surgical centers.
Valuation, performance and analyst views
Recent coverage has drawn attention to the stock's valuation and its performance compared with benchmarks and peers. Intuitive Surgical shares have lagged the broader market over the past months while still trading at a premium valuation multiple. According to Zacks on September 14, 2026, Intuitive Surgical carries a forward price-to-earnings ratio of 34.39 and trades at a price-earnings-growth (PEG) ratio of 2.3, both reflecting a growth premium but below some of its historical valuation levels.
In the same Zacks snapshot, shares were described as having fallen 6.43 percent over the prior month, compared with a 2.01 percent loss for the medical sector and an 0.82 percent decline for the S&P 500 over that period. Zacks currently assigns Intuitive Surgical a Rank 3 (Hold), indicating a neutral stance in its proprietary rating system.
Medium-term performance has also been subdued. An options-focused analysis from Trefis on September 14, 2026, pointed out that Intuitive Surgical traded near USD 370, about 38 percent below its 52-week high, with the stock down around 18 percent over the past year while the S&P 500 gained close to 19 percent.
Competitive landscape and AI as a driver
Competition in robotic-assisted surgery is intensifying, and analysts are watching whether Intuitive Surgical can maintain its lead as new platforms emerge. A recent sector piece from Yahoo Finance on September 14, 2026 discussed how Intuitive Surgical is integrating artificial intelligence and data capabilities into its ecosystem as it faces increasing competition from other robotic surgery providers.
According to that overview, Intuitive Surgical's shares had lost 33.6 percent year to date as of mid-September 2026, compared with a 10.8 percent decline for its broader industry group. The piece noted that the stock traded at a forward price-to-earnings multiple of 31.8 times, above the industry average but significantly below its five-year median of 67.91 times, and that the consensus estimate for the company's 2026 earnings implied growth of 20.3 percent versus the prior year. Yahoo Finance also reported that Intuitive Surgical carried a Zacks Rank 3 (Hold) and a Value Score of D, reflecting its premium valuation.
From a strategic standpoint, the MoneyDJ summary in ???? underscored that the most notable signal in the current phase is the simultaneous expansion of installed systems, leasing deployments and procedure volumes. For investors, these figures suggest that Intuitive Surgical is not only selling more da Vinci systems but also deepening their usage, which can support recurring instrument and service revenue.
Stock performance and current price context
Intuitive Surgical's latest closing price of USD 377.94 on Nasdaq as of September 14, 2026 positions the stock well below its recent 52-week high but after several sessions of recovery. As noted by MarketWatch, the 2.38 percent gain on September 14, 2026 came on a day when the S&P 500 fell 0.48 percent and the Dow Jones Industrial Average dropped 0.29 percent, meaning Intuitive Surgical outperformed major indices on that session.
Key data on Intuitive Surgical stock
- Company: Intuitive Surgical, Inc.
- ISIN: US46120E6023
- Ticker: ISRG
- Trading venue: Nasdaq
- Price (as of September 14, 2026, 4:00): 377.94 USD
- Market capitalization: [value] USD (as of September 14, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
